Siemens opens Cologne research centre

Siemens Healthcare has opened a new research centre in Cologne, where around 40 employees are developing new diagnostic tests to describe the molecular characteristics of breast cancer cells, to help physicians to select individual therapy.

Siemens has also been researching innovative biochips for breast cancer tests. ‘Biochips can perform hundreds and, in extreme cases, hundreds of thousands of diagnostic tests simultaneously. Many different tumour characteristics must be investigated in order to identify the possibility of various therapies,’ the firm points out. ‘Biochips are therefore especially suitable for performing a high number of required tests both fast and efficiently.’
The Siemens ‘Breast Care Solutions’ package combines various imaging techniques including ultrasound, mammography and magnetic resonance imaging, and these are now supplemented by laboratory diagnostic tests and DP based evaluation systems.


Read all latest stories

Related articles


Sponsored • Earlier disease prediction and identification

The potential of AI in routine blood testing

It’s widely known that more than 70% of today’s medical decisions involve the results of laboratory tests, but the insights clinicians derive from these tests today may only be scratching the…


Sponsored • Siemens Naeotom Alpha

First CT scanner with photon-counting technology

Conventional CT imaging has reached its technical limitations: Resolution can only be improved by small margins and dose cannot be reduced significantly: Photon-counting technology enables drastic…


Sponsored • Photon-counting CT scanner

No detours, more detail

For the Siemens Healthineers team developing new and ever higher performing computed tomographs is daily fare. But when they introduced their most recent CT system an unusual sense of pride was…

Related products

Subscribe to Newsletter